The SPAC and its pharma-cannabis target in a filing included an investor presentation covering the revised deal terms. Read more.
Related Posts
Spire Global Merging With NavSight at $1.6B Valuation
The transaction is expected to provide approximately $475 million in gross proceeds, assuming no redemptions, and includes a $245 million PIPE.
Riverview Acquisition Files for $250M IPO
The SPAC said it may decide "to target consumer-focused enterprises, including e-commerce, on the renewables and energy services sector, and/or on the insurance and financial services sector."
Hennessy V Files for $250M IPO
The SPAC will target companies focused on sustainable industrial technology and infrastructure sectors.
Population Health Amends $150M IPO
The SPAC's latest filing in advance of its $150M IPO amends articles of association.